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The capacity of Staphylococcus aureus to form biofilms on host tissues and implanted medical devices is one
of the major virulence traits underlying persistent and chronic infections. The matrix in which S. aureus cells
are encased in a biofilm often consists of the polysaccharide intercellular adhesin (PIA) or poly-N-acetyl
glucosamine (PNAG). However, surface proteins capable of promoting biofilm development in the absence of
PIA/PNAG exopolysaccharide have been described. Here, we used two-dimensional nano-liquid chromatogra-
phy and mass spectrometry to investigate the composition of a proteinaceous biofilm matrix and identified
protein A (spa) as an essential component of the biofilm; protein A induced bacterial aggregation in liquid
medium and biofilm formation under standing and flow conditions. Exogenous addition of synthetic protein A
or supernatants containing secreted protein A to growth media induced biofilm development, indicating that
protein A can promote biofilm development without being covalently anchored to the cell wall. Protein
A-mediated biofilm formation was completely inhibited in a dose-dependent manner by addition of serum,
purified immunoglobulin G, or anti-protein A-specific antibodies. A murine model of subcutaneous catheter
infection unveiled a significant role for protein A in the development of biofilm-associated infections, as the
amount of protein A-deficient bacteria recovered from the catheter was significantly lower than that of
wild-type bacteria when both strains were used to coinfect the implanted medical device. Our results suggest
a novel role for protein A complementary to its known capacity to interact with multiple immunologically
important eukaryotic receptors.
Staphylococcus aureus is a gram-positive bacterium that lives
as part of the normal microflora on the skin and mucous
membranes of humans and animals. If S. aureus passes through
the epithelial barrier and reaches internal organs, it can cause
a variety of diseases, ranging from minor skin infections, such
as furuncles or boils, to severe infections, such as bacteremia,
pneumonia, osteomyelitis, or endocarditis. Despite the
progress with antibiotics in the treatment of bacterial infec-
tions over the last 2 decades, the number of infections due to
S. aureus has increased (11, 30). The infection rate has been
correlated with an increase in the use of prosthetic and in-
dwelling devices in modern medical practices (24, 26). S. au-
reus, as well as other coagulase-negative staphylococci, displays
a strong capacity to irreversibly attach to the surface of im-
planted medical devices and forms multilayered communities
of bacteria, known as biofilms, that grow embedded in a self-
produced extracellular matrix (23). The biofilm formation pro-
cess occurs in two steps: first, bacterial cells irreversibly attach
to a surface, and second, they interact with each other and
accumulate in multilayered cell clusters embedded in a self-
produced extracellular matrix. Primary attachment is mediated
by physico-chemical cell surface properties as well as specific
factors that mediate the attachment to the host-derived extra-
cellular matrix components that rapidly coat the biomaterial
following insertion into the patient. Numerous proteins from
the MSCRAMMs family (microbial surface components rec-
ognizing adhesive matrix molecules) are involved in the first
step of S. aureus biofilm formation, such as clumping factors
ClfA (37) and ClfB (41) and fibrinogen and fibronectin binding
proteins (FnBPA and FnBPB) (25, 31). Once bacteria accu-
mulate in multilayered cell clusters, most have no direct con-
tact with the surface, and thus cell-to-cell interactions become
essential for biofilm development and maintenance. An extra-
cellular polysaccharide intercellular adhesin (PIA, or PNAG),
produced by icaADBC operon-encoded enzymes, is currently
the best-characterized element mediating intercellular interac-
tions in vitro (8, 23, 34, 35, 38). Alternatively, a number of
surface proteins can replace PIA/PNAG exopolysaccharide in
promoting intercellular adhesion and biofilm development, in-
cluding the surface protein Bap (9). All the tested staphylo-
coccal isolates harboring the bap gene were shown to be strong
biofilm producers, and inactivation of the icaADBC operon in
bap-positive strains had no effect on in vitro biofilm formation
(57). Remarkably, proteins homologous to Bap are involved in
the biofilm formation process in diverse bacterial species (33).
A second surface protein, SasG, as well as its homologous
protein in Staphylococcus epidermidis, Aap, also mediates in-
tercellular interactions and biofilm development in the absence
of the ica operon (7, 51). More recently, two independent
laboratories have shown that fibronectin binding proteins A
and B (FnBPA and FnBPB) induce biofilm development of
* Corresponding author. Mailing address: Instituto de Agrobiotec-
nología, Universidad Pu´blica de Navarra, Pamplona 31006, Spain.
Phone: 34 948 168007. Fax: 34 948 232191. E-mail: ilasa@unavarra.es.
 Published ahead of print on 1 December 2008.
832
 o
n
 January 9, 2019 by guest
http://jb.asm.org/
D
ow
nloaded from
 
clinical isolates of S. aureus (45, 55). Finally, there is growing
evidence that extracellular DNA, despite not being sufficient to
replace PIA/PNAG exopolysaccharide, is an important S. au-
reus biofilm matrix component (50).
During the course of a systematic mutagenesis study of the 17
two-component systems of S. aureus that aimed to identify bio-
film-negative regulators, we found that S. aureus agr arlRS double
mutants developed an alternative, ica-independent biofilm in a
chemically defined medium, Hussain-Hastings-White (HHW)
medium (56). This study focused on the identification of the
proteinaceous compound responsible for the biofilm developed
by S. aureus agr arlRS mutants. Here, we show that S. aureus
protein A is responsible for the aggregative phenotype and ca-
pacity for biofilm formation displayed by this strain. Furthermore,
overproduction of protein A in wild-type S. aureus strains or
addition of soluble protein A to bacterial growth medium induced
aggregation and biofilm development, suggesting that protein A
does not need to be covalently linked to the cell wall to promote
multicellular behavior. Moreover, deletion of the spa gene signif-
icantly decreased the capacity of S. aureus to colonize subcutane-
ously implanted catheters. Our findings support a novel role for
protein A in promoting multicellular behavior and suggest that
protein A-mediated biofilm development may have a critical
function during the infection process of S. aureus.
MATERIALS AND METHODS
Bacterial strains, culture conditions, and plasmids. The most relevant bacte-
rial strains and plasmids used in this study are listed in Table 1. Escherichia coli
XL1-Blue cells were grown in Luria-Bertani broth or on Luria-Bertani agar
(Pronadisa, Madrid, Spain) with appropriate antibiotics. Staphylococcal strains
were cultured using different media: trypticase soy agar (TSA), trypticase soy
broth supplemented with glucose (0.25%, wt/vol) (TSBg), and chemically defined
HHW modified (HHWm) medium. Lactococcus lactis strains were incubated in
M17 medium (Pronadisa, Madrid, Spain). Media were supplemented with ap-
propriate antibiotics at the following concentrations: erythromycin (Er), 20 g
ml1, 1.5 g ml1, or 10 g ml1; ampicillin (Am), 100 g ml1; chloramphen-
icol (Cm), 20 g ml1; kanamycin (Km), 50 g ml1; tetracycline (Tet), 10 g
ml1. When required, TSA was supplemented with 5-bromo-4-chloro-3-indolyl-
-D-galactopyranoside (Bioline, London, United Kingdom).
DNA manipulations. DNA plasmids were isolated from E. coli strains using
the Qiagen plasmid mini prep kit (Bio-Rad Laboratories, Inc.) according to the
manufacturer’s protocol. Plasmids were transformed into staphylococci by elec-
troporation, using a previously described protocol (9). Restriction enzymes were
purchased from Takara Shuzo Co. Ltd. or New England Biolabs and used
according to the manufacturers’ instructions. Oligonucleotides were obtained
from Thermo (Electron Corporation). The srtA gene was inactivated in S. aureus
ISP479r agr by transferring srtA::ermC from S. aureus Newman srtA (36) by phage
transduction using 85 (42).
Allelic exchange of chromosomal genes. To construct the deleted strains, we
amplified by PCR two fragments of approximately 800 bp that flanked the left
side (oligonucleotides A and B) and the right side (oligonucleotides C and D) of
the sequence targeted for deletion (Table 2). The two obtained fragments were
cloned in the pGEM-T Easy vector (Promega). Oligonucleotides B and C carry
the same restriction site at the 3 and 5 ends, respectively, so that it is possible
TABLE 1. Strains and plasmids used in the study
Strain or plasmid Relevant characteristic(s) Reference
S. aureus strains
ISP479r ISP479c rsbU restored 56
ISP479r arlRS ISP479r arlRS operon 56
ISP479r agr ISP479r agr::tet 56
ISP479r agr spa ISP479r agr::tet spa This study
ISP479r agr arlRS ISP479r agr::tet arlRS operon 56
ISP479r agr arlRS srtA ISP479r agr::tet arlRS srtA::ermC This study
ISP479r agr arlRS spa ISP479r agr::tet arlRS spa This study
ISP479r agr arlRS sdrD ISP479r agr::tet arlRS sdrD This study
ISP479r agr pCN40 ISP479r agr transformed with pCN40 plasmid This study
ISP479r agr arlRS pCN40 ISP479r agr arlRS transformed with pCN40 plasmid This study
ISP479r agr arlRS spa pCN40 ISP479r agr arlRS spa transformed with pCN40 plasmid This study
ISP479r agr arlRS spa pCN40spa ISP479r agr arlRS spa complemented with spa gene This study
Newman 12
Newman srtA Newman srtA::ermC 36
Newman spa Newman spa::Km 44
Newman pCN40 Newman transformed with pCN40 plasmid This study
Newman pCN40spa Newman complemented with spa gene This study
Newman agr Newman agr::tet This study
Newman agr spa Newman agr::tet spa::Km This study
12313 Clinical strain isolate 56
Lactococcus lactis strains
MG1363 pKS80 Plasmid-cured L. lactis strain complemented with pSK80 plasmid 44
MG1363 pKS80spa Plasmid-cured L. lactis strain complemented with spa gene 44
Escherichia coli XL1-Blue Used for cloning assays
Plasmids
pMAD E. coli-S. aureus shuttle vector with bgaB gene encoding a -galactosidase; Apr/Err 1
pMAD spaAD pMAD plasmid containing the mutant allele for deletion of spa gene This study
pMAD sdrDAD pMAD plasmid containing the mutant allele for deletion of sdrD gene This study
pCN40 E. coli-S. aureus shuttle vector with constitutive promoter PblaZ 5
pCN40spa pCN40 plasmid containing spa gene This study
pCN40spaLPXTG pCN40 plasmid containing spa gene without charged tail and hydrophobic domain This study
VOL. 191, 2009 PROTEIN A INDUCES MULTICELLULAR BEHAVIOR 833
 o
n
 January 9, 2019 by guest
http://jb.asm.org/
D
ow
nloaded from
 
to fuse fragments AB and CD by ligation, creating the AD fragment. Besides,
oligonucleotides A and D carry restriction sites, so that it is possible to fuse the
AD fragment to the shuttle plasmid pMAD previously digested with the corre-
sponding enzymes. The resulting plasmids were transformed into S. aureus by
electroporation. pMAD contains a temperature-sensitive origin of replication
and an erythromycin resistance gene (1). Homologous recombination experi-
ments were performed as previously described (60). Erythromycin-sensitive
white colonies, which no longer contained the pMAD plasmid, were tested by
PCR using oligonucleotides E and F to confirm the gene replacement.
Complementation studies. The spa gene was amplified with thermophylic
DNA polymerase (Certamp long amplification kit; Biotools, Spain) from S.
aureus strain ISP479r with primers pCN40spa-1 and pCN40spa-2 (Table 2).
pCN40 is a staphyloccus-E. coli shuttle vector that harbors the constitutive PblaZ
promoter (43). The PCR product was cloned into pCN40 (pCN40spa) so that it
was expressed under the PblaZ promoter. This plasmid and the vector control
were introduced in the different strains by phage transduction using 85 (42).
The spa gene lacking the carboxy-terminal region was amplified from strain
ISP479r by PCR with primers pCN40spa-1 and pCN40spa-3 and it was cloned
into pCN40 to create the pCN40spa LPXTG plasmid. This plasmid was intro-
duced in ISP479r agr arlRS spa by phage transduction using 85.
Surface-associated protein preparation. Surface protein preparations were
obtained from S. aureus cells under iso-osmotic conditions. Bacterial cells were
recovered from 5-ml overnight cultures by centrifugation, washed twice in 1 ml
of phosphate-buffered saline (PBS), and resuspended in 100 l of iso-osmotic
digestion buffer (PBS containing 26% [wt/vol] raffinose). After addition of 3 l
of a 1-mg/ml solution of lysostaphin (Sigma), the preparations were incubated
with shaking at 37°C for 2 h. Protoplasts were sedimented by centrifugation at
8,000  g for 30 min with slow deceleration, and the supernatant was analyzed
by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) or
stored at 20°C.
Biofilm formation assays. A biofilm formation assay in microtiter wells was
performed as described previously (28). Briefly, 5 l of a culture of S. aureus
grown overnight in HHWm or TSBg at 37°C was inoculated into the wells of
microtiter plates (Iwaki) containing 195 l of HHWm or TSBg (final dilution of
the culture, 1:40). After 24 h of incubation at 37°C, the microplates were washed
three times with 200 l of H2O, dried in an inverted position, and stained with
100 l of 0.25% crystal violet for 2 to 3 min at room temperature. Then, the
microplates were rinsed again three times with H2O and dried, the dye was
subsequently dissolved in 200 l of ethanol-acetone (80:20), and the absorbance
was measured at 595 nm. For the biofilm formation inhibition assay we used a
nonspecific rabbit serum, purified immunoglobulin G (IgG [I5006]; Sigma), and
anti-protein A-specific antiserum (P3775; Sigma) at concentrations ranging from
500 g/ml to 3.6 g/ml. Then, a biofilm formation assay was performed as
described above. To analyze biofilm formation under flow conditions, we used
60-ml microfermentors (Pasteur Institute; (www.pasteur.fr/recherche/unites/Ggb
/biofilmfermenter.html) with a continuous flow of 40 ml of chemically defined
medium h1 and constant aeration with sterile pressed air. Submerged Pyrex
slides served as the growth substratum. Bacteria from an overnight culture grown
at 37°C with aeration in chemically defined media were diluted to an optical
density (OD) at 600 nm of 1. For the inoculations, the Pyrex slides were intro-
duced in the bacterial solution for 2 min and placed back in the microfermentors.
The microfermentors were cultivated for 24 h at 37°C. Biofilm development was
recorded with a Nikon Coolpix 950 digital camera. To quantify the 24-h biofilm,
bacteria that adhered to the surfaces of the Pyrex slides were resuspended in 10
ml of chemically defined medium. The OD of the suspension was measured at
650 nm. Biofilm formation assays in the presence of supernatants were per-
formed as follows. Supernatants from ISP479r agr arlRS (supernatant 1),
ISP479r agr arlRS spa complemented with pCN40spa (supernatant 2),
ISP479r agr arlRS spa (supernatant 3), and ISP479r agr arlRS spa comple-
mented with a truncated version of protein A that lacks the LPXTG domain
(supernatant 4) were obtained after centrifugation of an overnight culture at
2,800 rpm for 20 min. Filtered supernatants were added 1:1 (vol/vol) to ISP479r
agr arlRS spa cultures. Soluble commercial protein A (P3838; Sigma) was
added at a concentration of 10 g/ml. Then, the biofilm formation assay was
performed as previously described.
Cell aggregation assay. Liquid cultures of S. aureus ISP479r agr arlRS,
ISP479r agr arlRS spa, Newman pCN40, Newman pCN40spa, and Lactococcus
lactis MG1363 pKS80 and MG1363 pKS80spa were separately grown overnight
in HHWm, TSBg, or M17. Cultures were adjusted to an OD600 of 2.5. Cultures
of 3 ml were incubated in 5-ml standing tubes at room temperature, and the
OD600 of the upper part of the culture was measured throughout time. Assays
were performed in triplicate.
Electrophoresis and Western blot analysis. Electrophoretic separation of cell
wall-associated protein preparations was carried out by SDS-PAGE. The acryl-
amide concentration was 12% in the resolving gel and 5% in the stacking gel. For
Western blotting, proteins were transferred to Hybond-ECL nitrocellulose mem-
branes (GE Healthcare) by electroblotting. The buffer used for transfer was 50
mM Tris (pH 8.3)–380 mM glycine–0.1% SDS–20% methanol. The blocking
solution contained PBS, 5% milk powder, and 0.1% Tween 20. Probing was
carried out only using a secondary antibody taking into account the property of
protein A to bind the Fc region of the Igs. Nitrocellulose membranes were
washed with PBS-Tween and then incubated for 1 h at room temperature with a
1:5,000 dilution of a peroxidase-conjugated AffiniPure rabbit anti-sheep IgG
(Jackson InmunoResearch Laboratories, Inc.). The reaction was developed using
the ECL Western blotting analysis system (GE Healthcare). Images were ob-
tained with a Chemi-Doc apparatus (Bio-Rad).
Preparation of S. aureus strains for the two-dimensional nano-liquid chroma-
tography and ion trap mass spectrometric (2DnLC-MS/MS) analysis. Bacterial
strains were grown overnight at 37°C in HHW growth medium. A 200-ml aliquot
of fresh medium was then inoculated with a 1:10 dilution of the overnight culture
and grown until an OD650 of 1 was reached. Bacteria were spun down by
centrifugation (14,000 rpm, 10 min, 4°C) and washed twice with a 1/10 volume of
the original culture in PBS. The bacteria were fixed for 1 h at 4°C in 20 ml of a
solution containing 3% paraformaldehyde and then washed twice with ultrapure
H2O. Fixed bacteria were resuspended in a 1/10 volume of the original culture of
ammonium bicarbonate, 50 mM, and modified trypsin (sequencing grade; Pro-
mega, Madison, WI) was added at a final amount of 1 g per sample. Digestion
with trypsin was performed under shaking conditions for 1 h at 37°C. Digested
peptides were separated from the bacterial cells by centrifugation (300,000  g,
20 min, 30°C). The supernatant containing the peptide mixture was lyophilized
and kept at 20°C.
2DnLC-MS/MS analysis. The tryptic peptide mixtures (4 g each) were in-
jected onto a strong cationic exchange micro-precolumn (500 m inner diameter
[ID] by 15 mm; BioX-SCX; LC Packings, Amsterdam, The Netherlands) with a
flow rate of 30 l/min as a first-dimension separation. Peptides were eluted from
the column as fractions by injecting three salt steps of increasing concentrations
of ammonium acetate (10, 100, and 2,000 mM). Each of the three fractions
together with the nonretained fraction was on-line injected onto a C18 reversed-
phase microcolumn (300 m ID by 5 mm; PepMap; LC Packings) to remove
salts, and the peptides were analyzed in a continuous acetonitrile gradient con-
sisting of 0 to 50% B in 45 min and 50 to 90% B in 1 min (B is 95% acetonitrile,
0.5% acetic acid in water) on a C18 reversed-phase self-packing nano-column
(100 m ID by 15 cm; Discovery BIO Wide pore; Supelco, Bellefonte, PA). A
flow rate of 300 nl/min was used to elute peptides from the reversed-phase
nanocolumn to a PicoTip emitter nano-spray needle (New Objective, Woburn,
MA) for real-time ionization and peptide fragmentation on an Esquire HCT ion
trap mass spectrometer (Bruker-Daltonics, Bremen, Germany). Every 1 s, the
instrument cycled through acquisition of a full-scan mass spectrum and one
MS/MS spectrum. A 4-Da window (precursor m/z 	 2), an MS/MS fragmenta-
tion amplitude of 0.80 V, and a dynamic exclusion time of 0.30 min were used for
TABLE 2. Oligonucleotides used in the study
Name Sequence
spa-A.............................5-GAATTCCAATTCTAGCTATTATCACTT-3
spa-B .............................5-TCTAGAATTAATACCCCCTGTATGTA-3
spa-C .............................5-TCTAGAAAACAAACAATACACAACGAT-3
spa-D.............................5-GGATCCTTAAAATGGAAAAGTGCAGG-3
spa-E .............................5-GATGATGTATACAATGTATTTC-3
spa-F .............................5-TGCGTCTCGATTTAATTGG-3
spa-G.............................5-GAATTCCACTTAAAACCATTTCCGAA-3
spa-H.............................5-GGATCCATCGTTGTGTATTGTTTGTTT-3
pCN40spa-1..................5-GGATCCAAGTTGTAAAACTTACATTTAAA-3
pCN40spa-2..................5-GAATTCATCGTTGTGTATTGTTTGTTT-3
pCN40spa-3..................5-GAATTCTTATGATAATCCACCAAATACAG-3
sdrD-A ..........................5-GGATCCGTTACAGAAATGTAATTGTCTATG-3
sdrD-B...........................5-AGTTGCTGCATATCAACTTTATC-3
sdrD-C...........................5-CAGCTTATACCAGGTCCGTG-3
sdrD-D ..........................5-CCATGGTGTTGAATCATTTTCTGTTGTCG-3
sdrD-E...........................5-GATTAACTTAACCAGGTCCATG-3
sdrD-F ...........................5-CTTTAGCTTCTGGTTGTGAATC3
arlRS-E .........................5-GGATCCTTGATTGATTGACGTCTCAGTCAT-3
arlRS-F..........................5-AAGCTTGTGAAATGTTTAAACTACGG-3
spa-Fw...........................5-GCAAACGGCACTACTGCTGA-3
spa-Rv ...........................5-CACCAGTTTCTGGTAATGCTTGAG-3
gyr-Fw............................5-TTATGGTGCTGGGCAAATACA-3
gyr-Rv............................5-CACCATGTAAACCACCAGATA-3
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peptide fragmentation. 2DnLC was automatically performed on an advanced
microcolumn switching device (Switchos; LC Packings) coupled to an autosam-
pler (Famos; LC Packings) and a nano-gradient generator (Ultimate nano-
HPLC; LC Packings). The software Hystar 2.3 was used to control the whole
analytical process.
Database analysis. MS/MS spectra were batch processed by using DataAnalysis
5.1 SR1 and MS BioTools 2.0 software packages and searched against the S.
aureus protein databases using Mascot software (Matrix Science, London,
United Kingdom).
Real-time quantitative PCR. Total S. aureus RNA was prepared using the Fast
RNA-Blue kit (Bio101) according to the manufacturer’s instructions. Two mi-
crograms of each RNA was subjected in triplicate to DNase I (Gibco-BRL)
treatment for 30 min at 37°C. The enzyme was inactivated at 65°C in the presence
of EDTA. To verify the absence of genomic DNA in every sample, the RNA
triplicates were reverse transcribed in the presence and absence of Moloney
murine leukemia virus reverse transcriptase (Gibco-BRL). All preparations were
purified using CentriSep spin columns (Princeton Separations). A 1/20 fraction
of each reaction mixture was used for real-time quantitative PCR using a Light-
Cycler and the SYBR Green PCR master mix (Applied Biosystems). The spa
transcripts were amplified using primers spa-FW and spa-RV (Table 2). The gyrB
transcripts that are constitutively expressed were amplified as endogenous con-
trols using primers gyr-FW and gyr-RV (63) (Table 2). To monitor the specificity,
final PCR products were analyzed by melting curves and electrophoresis. Only
samples with no gyrB amplification of the minus reverse transcriptase aliquot
were considered in the study. The amount of spa transcript was expressed as the
difference relative to the control gene (2Ct, where Ct represents the differ-
ence in threshold cycle between the target and control genes).
Immunofluorescence microscopy. Immunofluorescence microscopy analysis
was performed as previously described (61). Overnight cultures of the different
strains were diluted to an OD650 of 1 in HHW and 10 l was loaded onto 0.1%
poly-(L-lysine)-treated immunofluorescence microscope slides. Slides were
washed three times with PBS between each step of this protocol. Cells were fixed
with 3% paraformaldehyde for 10 min before quenching with 50 mM NH4Cl in
PBS for 3 min. Slides were then saturated for 15 min with 0.5% bovine serum
albumin in PBS before being incubated with a 1:200 dilution of a secondary
anti-mouse IgG (whole molecule) antibody produced in rabbit (Sigma) conju-
gated to tetramethyl rhodamine isothiocyanate (TRITC). Finally, the slides were
mounted with Vectashield HardSet mounting medium with 4,6-diamidino-2-
phenylindole (Vector Laboratories) and observed under an epifluorescence mi-
croscope with rhodamine and DAPI filters.
Experimental infection. A mouse foreign body infection model was used to
determine the role of protein A in the pathogenesis of S. aureus. A total of 60
adult male mice (Swiss-Albino) were used. A 1-cm segment of intravenous
catheter (24 gauge; B. Braun) was aseptically implanted into the subcutaneous
interscapular space. Each group of mice was coinoculated with 105 CFU of both
S. aureus Newman and the spa mutant strain (spa::Km). The animals were
euthanatized by cervical dislocation on days 3 or 7 postinfection. The catheter
was aseptically removed, placed in a sterile tube containing 1 ml of TSBg,
sonicated, and vortexed at high speed for 3 min. The CFU/catheter was deter-
mined by plating bacteria in either TSA or TSA-Km (50 g/ml). An extra group
of animals was inoculated with vehicle (PBS) and served as a negative control.
The experiment was repeated twice.
Statistical analysis. A two-tailed Student’s test with Welch’s correction was
used to assess significant differences in bacterial recovery within groups in ex-
perimental infections. Differences were considered statistically significant when P
was 
0.05. The GraphPad 5.0 statistical package was used (GraphPad Software,
San Diego, CA).
RESULTS
Non-gel analysis of the S. aureus cell wall proteome. To
identify the protein component responsible for the PIA/
PNAG-independent biofilm development in agr arlRS mutants,
we first generated a mutant of the sortase A gene (srtA) in
ISP479r agr arlRS strain. Sortase A was selected because it
catalyzes the cell wall anchoring of the LPXTG family of sur-
face proteins. Biofilm formation assays revealed that deletion
of srtA completely inhibited the biofilm phenotype displayed by
the agr arlRS mutant, suggesting that an LPXTG protein was
essential for the biofilm-forming capacity of these strains (data
not shown). The cell wall proteomes of ISP479r agr and its
corresponding isogenic arlRS mutant were then compared by
2DnLC-MS/MS. Fixed bacterial cells were digested with tryp-
sin as described in Materials and Methods to yield a peptide
mixture that was fractionated and analyzed by 2DnLC coupled
to electrospray ionization and mass spectrometry (4). Two
LPXTG proteins, protein A and SdrD, were detected in the
cell wall proteome of the ISP479r agr arlRS mutant (data not
shown). In contrast to SdrD, protein A was also detected in the
cell proteome of the ISP479r agr strain. To confirm that the
levels of protein A were higher on the surface of ISP479r agr
arlRS compared to the wild-type ISP479r agr strain, the in-
tensities of extracted ion chromatograms (EIC) were com-
pared. As shown in Fig. 1, the intensity of the ions correspond-
ing to the trypsin-digested peptides from protein A was fivefold
higher in the arlRS sample, confirming that protein A is
present at higher levels in the arlRS mutant compared to the
wild-type strain. In contrast, and as a control, analysis of the
EIC corresponding to the tryptic peptides from the ClpB pro-
tein showed that the intensity of the signals was almost iden-
tical in both strains, indicating that the amount of ClpB on the
surface of both bacteria is similar. Overall, these results dem-
onstrate that the LPXTG proteins, protein A and SdrD, were
present at higher levels on the cell surface of the S. aureus agr
arlRS double mutant than in the agr-deficient strain.
Deletion of the spa gene causes a decrease in the biofilm
development promoted by the arlRS mutation. We then asked
whether either of the two LPXTG proteins whose levels are
augmented in double agr arlRS mutant strains was responsible
for the biofilm formation phenotype. We deleted the spa and
FIG. 1. EICs of protein A and ClpB in S. aureus ISP479r agr and
ISP479r agr arlRS strains. On the left is the EIC from ions at m/z
783.38 (ion 1), 816.07 (ion 2), and 825.4 (ion 3) Da, corresponding to
protein A-derived tryptic, triply charged peptides spanning sequences
shown below. Ionic intensity from the three detected signals was in-
creased fivefold in the arlRS sample. On the right is the EIC for ions
at m/z 794.37 (ion 4) and 796.37 (ion 5) Da, corresponding to doubly
and triply charged tryptic peptides, respectively, from the ClpB pro-
tein, which is expressed at the same levels in both samples. Retention
times for the ISP479r agr arlRS sample have been shifted 1 minute to
avoid chromatogram overlapping.
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sdrD genes in the ISP479r agr arlRS strain. Biofilm assays in
polystyrene petri dishes revealed that only deletion of the spa
gene inhibited the biofilm formation capacity, whereas dele-
tion of sdrD had no effect (Fig. 2A). This result indicated that
protein A was responsible for the development of biofilm in agr
arlRS strains. To verify this finding, complementation studies
were performed. When pCN40spa was introduced into ISP479r
agr arlRS spa, the biofilm phenotype was completely re-
stored, confirming that inactivation of spa was responsible for
the biofilm negative phenotype of this strain (Fig. 2B). Immu-
noblotting assays demonstrated that the levels of protein A
were elevated in the ISP479r agr arlRS strain compared to the
corresponding single mutants and wild-type strain (Fig. 2C).
To investigate whether this increase of protein A expression
observed in the agr arlRS mutant was due to augmented ex-
pression of the spa gene, we employed real-time quantitative
PCR. In agreement with previous results (16), the levels of spa
gene expression were not affected by arlRS deletion (Fig. 2D).
Taken together, these results indicated that protein A is an
essential component of the biofilm produced by agr arlRS
strains and that these strains accumulate higher levels of pro-
tein A on their cell surface, promoting biofilm development in
vitro.
Protein A mediates biofilm development in the absence of a
functional agr system. Recent studies have suggested a role for
the agr system in S. aureus biofilm development, as agr mutants
exhibit a high propensity to form biofilms, and cells dispersing
from a biofilm have been observed to display an active agr
system (3, 64). Thus, we wondered whether protein A might be
responsible for the increased biofilm development displayed by
agr mutants. As shown in Fig. 2A, disruption of the spa gene in
the agr mutant completely inhibited biofilm development, sug-
gesting that increased accumulation of protein A in the ab-
sence of an active agr system is responsible at least in some
strains for the tendency of agr mutants to develop stronger
biofilms.
Protein A induces aggregation and biofilm formation under
flow cell conditions. To further investigate whether the in-
creased levels of protein A in agr arlRS strains were able to
induce other phenotypes associated with multicellular behav-
ior, we monitored cell-to-cell interactions in an aggregation
assay and biofilm formation capacity in a continuous flow cul-
ture on glass spatulas submerged in microfermentors (19). In
contrast to protein A-deficient bacteria that remained in sus-
pension, S. aureus agr arlRS strongly aggregated and rapidly
sedimented on the bottom of the tube (Fig. 3A). Accordingly,
visualization of both macroscopic biofilm development in mi-
crofermentors and biofilm cell density on the removable glass
spatulas inside the microfermentors showed that S. aureus agr
arlRS formed a robust biofilm after 24 h of incubation, in
contrast to its corresponding spa mutant (Fig. 3B). Together,
these results indicate that protein A promotes cell-to-cell in-
teractions and biofilm formation under flow conditions.
Expression of protein A leads to increased aggregation and
biofilm formation in wild-type S. aureus strains. We then
asked whether deletion or overexpression of protein A might
affect biofilm formation in wild-type S. aureus strains. We first
inactivated spa in S. aureus Newman strain, which does not
synthesize PIA/PNAG exopolysaccharide and displays a slight
or null capacity to form a biofilm in microtiter plates in
HHWm. As shown in Fig. 4, deletion of spa reduced the ca-
pacity of the strain to produce a biofilm in microfermentors,
but it did not cause any noticeable effect on the capacity of the
strain to produce a biofilm in microtiter plates. In agreement
FIG. 2. Biofilm formation phenotype in polystyrene microtiter
dishes in HHWm medium after 24 h of incubation. (A) S. aureus
ISP479r, S. aureus ISP479r agr, S. aureus ISP479r agr spa, ISP479r agr
arlRS, ISP479r agr arlRS spa, and ISP479r agr arlRS sdrD
strains. (B) S. aureus ISP479r agr, ISP479r agr arlRS, and ISP479r agr
arlRS spa strains with the pCN40 control plasmid and S. aureus
ISP479r agr arlRS spa strain complemented with the pCN40spa
plasmid carrying the spa gene under the PblaZ promoter. HHWm was
supplemented with 10 g/ml of erythromycin as needed. (C) Western
blot analysis for protein A expression of S. aureus ISP479r, ISP479r
arlRS, ISP479r agr, ISP479r agr arlRS, and ISP479r agr arlRS spa
strains. The blot was probed with a 1:5,000 dilution of a peroxidase-
conjugated AffiniPure rabbit anti-sheep IgG. (D) Real-time quantifi-
cation of spa gene expression in S. aureus strains ISP479r, ISP479r
arlRS, ISP479r agr, and ISP479r agr arlRS at mid-log exponential
phase (OD650, 0.6).
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with previous results, mutation of agr bestowed the capacity to
produce a biofilm in microtiter plate assay. Such increased
biofilm formation capacity was completely inhibited when the
spa gene was inactivated in the S. aureus Newman agr strain,
indicating that protein A was required for increased biofilm
development in the absence of agr.
Then, we expressed protein A in S. aureus strain Newman
from the multicopy plasmid pCN40. The results revealed that
overexpression of protein A elicited aggregation in liquid cul-
ture and biofilm development in both polystyrene microtiter
plates and microfermentors under flow conditions (Fig. 5A and
B). To generalize the effects of protein A in multicellular
behavior, we heterologously expressed protein A in Lactococ-
cus lactis (Fig. 5C) and observed an increased aggregation
phenotype indicative of bacterial clumping. Overall, these re-
sults demonstrate that production of protein A is sufficient to
mediate biofilm development in wild-type S. aureus strains and
cell-to-cell interactions in both wild-type S. aureus and L. lactis
strains.
Antibodies inhibit protein A-induced biofilm formation.
Protein A directly reacts with the Fc portion of immunoglobu-
lins (14). The IgG-binding regions of protein A consist of four
or five domains, depending on the S. aureus strain (32). Based
on this property, we reasoned that nonimmune binding of IgG
to protein A could sterically interfere with the capacity of the
protein to induce cell-cell interactions and biofilm formation.
To test this hypothesis, we performed biofilm formation assays
of S. aureus ISP479r agr arlRS, S. aureus Newman pCN40spa,
and S. aureus 12313 strains under the presence of increasing
concentrations of a rabbit nonspecific serum, purified IgG, or
polyclonal antibodies raised against protein A. The S. aureus
12313 strain was included as a control in the study, as its
biofilm formation capacity depends on the production of the
PIA/PNAG exopolysaccharide. We found that biofilm forma-
tion capacity of the ISP479r agr arlRS and Newman
pCN40spa strains was completely inhibited in a dose-depen-
dent manner by nonspecific rabbit serum, purified IgG, and
anti-protein A antibodies (Fig. 6). However, similar concen-
trations of antibodies did not affect the biofilm formation ca-
pacity of the clinical S. aureus 12313 strain. Taken together,
these results indicate that interaction of antibodies with pro-
tein A sterically block the capacity of protein A to mediate
biofilm development; this finding provides further evidence of
the requirement for protein A in the biofilm development
process.
Extracellular protein A induces biofilm formation. Protein
A belongs to the LPXTG family of proteins characterized by its
covalent linkage to the cell wall peptidoglycan. However, most
S. aureus strains secrete significant levels of protein A (15 to
30%) into the cell culture (13). This prompted us to investigate
FIG. 3. (A) In vitro aggregation assay of S. aureus ISP479r agr arlRS and ISP479r agr arlRS spa strains. On the left side the aggregation
phenotype observed in glass tubes is shown, and on the right side the quantification of the optical density at 650 nm at different times is displayed.
Results of a representative experiment are shown. (B) Biofilm development of S. aureus ISP479r agr arlRS and ISP479r agr arlRS spa strains
grown in microfermentors under continuous flow of HHWm for 24 h at 37°C. The microfermentor (left) and the glass slides where bacteria form
the biofilm (right) are shown.
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whether protein A needs to be anchored to the cell wall to
promote multicellular behavior or if secreted protein A might
be functional. We first examined the levels of protein A in the
supernatants of ISP479r agr, ISP479r agr arlRS, ISP479r agr
arlRS spa, and ISP479r agr arlRS spa pCN40spa. Signif-
icant levels of protein A in the supernatants of the two biofilm-
positive strains, ISP479r agr arlRS and ISP479r agr arlRS
spa pCN40spa, were confirmed (Fig. 7A). Supernatants of
these bacterial strains, as well as pure commercial protein A
and a supernatant containing a modified protein A lacking the
LPXTG carboxy-terminal region, were added 1:1 (vol/vol) to
ISP479r agr arlRS spa cultures. As shown in Fig. 7B, addi-
tion of pure protein A or supernatants containing protein A
induced biofilm formation in the ISP479r agr arlRS spa
strain, whereas protein A-deficient supernatants did not im-
prove the biofilm formation capacity of this strain. Interest-
ingly, the protein A derivative lacking the LPXTG domain
retained the ability to induce biofilm formation. These results
indicate that secreted protein A is fully functional in promoting
biofilm development and suggest that protein A must interact
with some compound of the bacterial surface to mediate bio-
film development. To address this implication, we performed
immunofluorescence microscopy analysis (Fig. 8). Protein A
antiserum evenly bound to the cell surface of the ISP479r agr
arlRS spa strain when it was incubated with supernatants
containing extracellular protein A, confirming that extracellu-
lar protein A interacts with the bacterial cell surface.
Expression of protein A contributes to subcutaneous cath-
eter infection. To extend the relevance of our findings, we
FIG. 4. (A) Biofilm formation phenotype in polystyrene microtiter
dishes with S. aureus Newman wild-type strain and its corresponding
spa, agr, and spa agr mutant strains. (B) Biofilm development of S.
aureus Newman wild-type strain and its corresponding spa mutant
strain grown in continuous flow of HHWm for 24 h at 37°C. The glass
slides where bacteria formed the biofilm are shown.
FIG. 5. (A) Biofilm formation phenotype in polystyrene microtiter
dishes with S. aureus Newman wild-type strain complemented with the
pCN40 control plasmid and pCN40spa plasmid carrying the spa gene
under the PblaZ promoter in HHWm and TSBg supplemented with 10
g/ml of erythromycin. After 24 h of incubation, the microplates were
washed and stained with crystal violet; the dye was dissolved in 200 l
of ethanol-acetone (80:20). (B) Biofilm development of S. aureus New-
man wild-type strain with the pCN40 control plasmid and the
pCN40spa plasmid expressing the spa gene under the PblaZ promoter
grown in a continuous flow of HHWm or TSBg for 24 h at 37°C. The
glass slides where bacteria formed the biofilm are shown. (C) In vitro
aggregation assay in glass tubes. On the left side is S. aureus Newman
wild-type strain with the pCN40 control plasmid and the pCN40spa
plasmid carrying the spa gene under PblaZ promoter grown on HHWm
supplemented with 10 g/ml of erythromycin, and on the right side is
Lactococcus lactis wild-type strain complemented with the pKS80 con-
trol plasmid and the pKS80spa plasmid grown on M17 supplemented
with 10 g/ml of erythromycin.
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investigated the effects of protein A on the capacity of S. aureus
to colonize a subcutaneous foreign catheter. A 1-cm segment
of an intravenous catheter was aseptically implanted in the
subscapular space of mice, and animals were coinfected with
equal numbers of S. aureus Newman and the corresponding
protein A-deficient strain. The ratio of protein A and protein
A clones recovered from infected catheters after 3 and 7 days
was determined on agar plates with and without kanamycin.
The results of two independent experiments are presented in
Fig. 9. The number of protein A-positive colonies recovered
from the catheters was approximately 10 times higher than
protein A-negative colonies at day 3. Differences slightly in-
creased at day 7 (P 
 0.005, Student’s t test). These data
indicated that protein A significantly contributes to the devel-
opment of biofilm-associated infections caused by S. aureus.
DISCUSSION
Protein A, the first surface protein of S. aureus to be iden-
tified, has served as a model for the characterization of the
covalent anchorage of the LPXTG domain proteins by sortase
A to the bacterial cell surface (40, 53, 54). Protein A is pri-
marily known for its ability to bind to the Fc region of IgGs and
inhibit opsonophagocytosis (14, 59). The consequence of this
interaction is the coating of the bacterial surface with IgG
molecules in the incorrect orientation to be recognized by the
neutrophil Fc receptor (15). In addition, protein A can bind to
the human von Willebrand factor, a large multimeric glyco-
protein that mediates platelet adhesion at sites of endothelial
damage to promote the appearance of blood clots (27, 46).
Protein A also interacts with TNFR1 and stimulates an inflam-
matory response in airway epithelial cells (20, 21). In the
present work, we have identified a novel function for protein A
in the promotion of cell-to-cell interactions and biofilm forma-
tion by investigating the protein-dependent biofilm production
FIG. 7. (A) Western Blot analysis for protein A expression of the
supernatants of ISP479r agr, ISP479r agr arlRS, ISP479r agr arlRS spa
complemented with the pCN40spa, and ISP479r agr arlRS spa. The
cultures were grown overnight at 37°C in HHWm, and cells were collected
by centrifugation at 12,000 rpm for 2 min (the medium was supplemented
with 10 g/ml of erythromycin as needed). The supernatants were re-
solved by SDS-PAGE in a 12% polyacrylamide gel and then subjected to
Western blot analysis. The blot was probed with a 1:5,000 dilution of a
peroxidase-conjugated AffiniPure rabbit anti-sheep IgG. (B) Biofilm for-
mation phenotype of the ISP479r agr arlRS spa strain grown in the
presence of supernatants obtained from ISP479r agr arlRS (supernatant
1), ISP479r agr arlRS spa complemented with the pCN40spa (super-
natant 2), ISP479r agr arlRS spa (supernatant 3), and ISP479r agr
arlRS spa complemented with a truncated version of protein A that
lacks the LPXTG domain (supernatant 4). Additionally, ISP479r agr
arlRS spa was grown in the presence of pure commercial protein A
(Sigma). The supernatants were added 1:1 to the culture medium, and the
pure commercial protein A was added at a concentration of 10 g/ml.
After 24 h of incubation, the microplates were washed and stained with
crystal violet. The dye was dissolved in 200 l of ethanol-acetone (80:20).
FIG. 6. Concentration-dependent inhibition of biofilm formation on microtiter plates. Increasing concentrations of unspecific rabbit antiserum, a
purified IgG (Sigma), and specific anti-protein A antibodies (Sigma) were added to microtiter plates containing S. aureus ISP479r agr arlRS strains, S.
aureusNewman strain complemented with the pCN40spa plasmid carrying the spa gene under PblaZ promoter, and S. aureus strain 12313. The nonspecific
rabbit antiserum, commercial purified IgG, and anti-protein A-specific serum were used at concentrations ranging from 500 g/ml to 3.6 g/ml. HHWm
was supplemented with 10 g/ml of erythromycin as needed. After 24 h of incubation, the microplates were washed and stained with crystal violet.
VOL. 191, 2009 PROTEIN A INDUCES MULTICELLULAR BEHAVIOR 839
 o
n
 January 9, 2019 by guest
http://jb.asm.org/
D
ow
nloaded from
 
of an agr arlRS double mutant (56). The regulation of protein
A by the agr system, and specifically by its effector molecule,
RNA III, has been well-characterized. Accumulation of RNA
III during the postexponential phase of growth represses spa
expression, not only at a transcriptional level but also by in-
hibiting its translation and inducing degradation of the stable
spa mRNA by the double-strand-specific endoribonuclease III
(RNase III) (6, 29, 43, 48). Thus, expression of protein A is
FIG. 8. Analysis of cell surface interactions of extracellular protein A by immunofluorescence microscopy. S. aureus ISP479r agr arlRS spa cells were
incubated with supernatants of ISP479r agr arlRS (supernatant 1), ISP479r agr arlRS spa pCN40spa (supernatant 2), and ISP479r agr arlRS spa
(supernatant 3), as well as pure protein A. The samples were washed twice with PBS and fixed with 3% paraformaldehyde in PBS before incubation with a 1:200
dilution of a secondary anti-mouse IgG (whole molecule)–TRITC rabbit antibody (Sigma). The slides were mounted with Vectashield HardSet mounting
medium with DAPI (Vector Laboratories) (see Materials and Methods for details). The experiment was repeated twice.
FIG. 9. A 1-cm segment of an intravenous catheter was aseptically implanted into the subcutaneous interscapular spaces of adult male mice.
Each group of five mice was coinoculated with 105 CFU of both S. aureus Newman and the spa mutant strain (spa::Km). The figure shows the
recovery from the implanted subcutaneous catheters with S. aureus Newman and the Newman spa::Km mutant. The boxes represent the means
and standard deviations of two independent experiments. Significant differences between the wild-type and mutant strains are represented by
asterisks (P 
 0.001) at day 3 and day 7 postinfection. Bacteria were not detectable in control animals at the end of the experimental period.
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induced at the exponential phase and repressed at the postex-
ponential phase, when the expression of RNA III is maximal.
In addition, arlRS has also been described as a repressor of spa
expression, due to the fact that mutation in either of the two
arlRS genes results in increased spa expression. The influence
of arlRS on protein A expression requires the participation of
agr or sarA regulators, as increased transcription was not ob-
served in either an agr or sarA mutant strain (16). In agreement
with these results, we did not observe significant upregulation
of spa mRNA levels in agr arlRS mutants. However, the agr
arlRS double mutant accumulates more protein A on the cell
surface than the agr mutant, suggesting that arlRS either post-
transcriptionally regulates spa mRNA stability or that de-
creased production of proteases due to the absence of arlRS
indirectly provokes an increased accumulation of protein A.
Whatever the molecular mechanism is, the final outcome of
the double agr arlRS mutation is an increased accumulation of
protein A on the bacterial surface. This accumulation together
with the fact that most S. aureus strains are unable to produce
PIA/PNAG exopolysaccharide in the HHWm synthetic me-
dium has facilitated for us the observation that protein A can
mediate biofilm formation. However, the effect of protein A on
biofilm formation is not restricted to this double mutant. Thus,
deletion of spa in wild-type strains reduces biofilm formation
capacity in microfermentors, whereas it does not produce no-
ticeable effects in microtiter plates, most likely because the
amount of protein A under these conditions does not reach the
threshold level required to promote cell-to-cell interactions
and biofilm formation. In support of this hypothesis, we
showed that overexpression of protein A or the increased ac-
cumulation of protein A in agr mutants induced biofilm devel-
opment in microtiter plates. This last result correlates with
previous data indicating that agr-deficient S. aureus mutants
form more robust biofilms compared to wild-type strains (2, 3,
62, 64). Initially, it was proposed that the surfactant properties
of -toxin encoded by RNA III limited the ability of the bac-
teria to form biofilms (62). More recently, it was shown that
activation of the agr system through the addition of the AIP
peptide at a physiological concentration represses biofilm de-
velopment and triggers the detachment of established PIA/
PNAG-independent biofilm matrix (3). The same study
showed that the biofilm matrix produced by inactivation of the
agr system was degraded by proteinase K and resistant to the
treatment with dispersin B. Accordingly, agr-mediated biofilm
detachment required the participation of extracellular pro-
teases, as it did not occur in the presence of protease inhibitors
or when the main protease encoding gene, aureolysin, was
mutated (3). All these results strongly suggest that a protein-
aceous compound is important for biofilm integrity and that
agr activity promotes the detachment of a proteinaceous bio-
film matrix. Our results support the idea that protein A is, at
least in some strains, the proteinaceous compound responsible
for biofilm development in S. aureus agr mutant strains.
Protein A-mediated aggregation and biofilm formation may
result from homophilic interactions between two protein A
molecules of neighboring cells. Such homophilic protein inter-
actions leading to an autoaggregation phenotype have been
described for protein H-mediated Streptococcus pyogenes cell
aggregation (18), hemagglutinin-mediated cell aggregation in
Bordetella pertussis (39), and antigen 43, which is involved in E.
coli biofilm formation (10). Alternatively, protein A could me-
diate heterophilic interactions with other surface proteins or
even with a nonproteinaceous cell wall structure. In support of
the former hypothesis, expression of protein A in L. lactis also
induced aggregation, likely via heterophilic interactions with a
compound that must be present on the cell wall of both bac-
teria. However, expression of protein A in L. lactis only in-
duced aggregation of bacterial cells and was not sufficient to
induce the development of a mature biofilm on microtiter
plates or on the glass slide in microfermenters, suggesting that
either additional factors are required for biofilm development
or that L. lactis is unable to produce biofilm under the exper-
imental conditions tested.
The covalent attachment of protein A to the bacterial sur-
face is not required for its ability to promote cell-to-cell inter-
actions. Thus, secreted protein A from S. aureus strains or a
protein A variant lacking the carboxy-terminal LPXTG do-
main is sufficient to induce biofilm development. In contrast to
Aap- or SasG-mediated biofilm development that must un-
dergo proteolytic processing to render the proteins active for
cell-to-cell interactions (7, 51), protein A induces biofilm de-
velopment in an agr arlRS mutant that produces low levels of
proteases. Indeed, it appears that the decreased production of
extracellular proteases is at least partially responsible for the
increased accumulation of protein A in this mutant and
thereby proteolytic processing seems to not be required to
activate protein A for biofilm development.
Several studies have demonstrated the role of protein A in
staphylococcal virulence. Protein A-defective mutants show
reduced virulence in murine models of septic arthritis, septi-
cemia, and skin abscesses, most likely due to the antiphagocytic
effect of protein A bound to the Fc fractions of the IgGs (47,
49). Protein A has also been shown to trigger apoptosis of
murine B cells that express antigen receptors with VH3-Fab
analogues, which likely contributes to immunosuppression dur-
ing S. aureus infection (22). In the present study, coinfection
experiments using a subcutaneous foreign device murine in-
fection model showed that protein A significantly contributed
to the development of biofilm-related infections. As these ex-
periments were performed with a wild-type Newman strain and
its corresponding protein A-deficient mutant, these results im-
ply the existence of physiological situations in which the levels
of protein A are sufficient to contribute to biofilm develop-
ment. We cannot exclude the possibility that the increased
susceptibility of protein A-defective mutants to phagocytosis
might be negatively affecting the survival of the bacteria in the
implanted catheter. However, if this were the case, we would
expect that the number of recovered protein A-deficient bac-
teria would decrease throughout the duration of the experi-
ment. However, similar numbers of protein A-deficient bacte-
ria were recuperated at days 3 and 7, suggesting that survival of
the bacteria does not decrease during the infection period.
In summary, our results indicate that two of the conse-
quences of inactivation of the agr system, namely, overexpres-
sion of protein A and induction of biofilm formation capacity,
are related. Whether the common observed agr-negative vari-
ants during the course of the infection (17, 52, 58) may lead to
the establishment of bacterial interactions and biofilm forma-
tion to evade the immune system is an interesting hypothesis
that warrants further experiments.
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